α-SMA+ myofibroblast-like cellsBiomarker1 paperAnimals1LatestJCI Insight·23 JanTreatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortalityExperiments in miceAtherosclerosisPaperbioRxiv·28 JulTreatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortalityPreprint: experiments in animalsInterventionsPaper
JCI Insight·23 JanTreatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortalityExperiments in miceAtherosclerosisPaper
bioRxiv·28 JulTreatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortalityPreprint: experiments in animalsInterventionsPaper